Raffaele Pellegrino

Dr. Raffaele Pellegrino

University of Campania "Luigi Vanvitelli", Caserta, Campania, Italy
orcid
Hepatogastroenterology Unit, University of Campania "Luigi V...

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2022 in Digestive and Liver Disease
Verified
Journal Article
Closed access
MRMarco Romano
Marco Romano
AGAntonietta Gerarda Gravina
Antonietta Gerarda Gravina
LELeonardo Henry Eusebi
Leonardo Henry Eusebi
Raffaele PellegrinoRaffaele Pellegrino
Raffaele Pellegrino
GPGiovanna Palladino
Giovanna Palladino
BGBastianello Germanà
Bastianello Germanà

19 March 2024 in Digestive and Liver Disease
Verified
Journal Article
Closed access
AGAntonietta Gerarda Gravina
Antonietta Gerarda Gravina
Raffaele PellegrinoRaffaele Pellegrino
Raffaele Pellegrino
GPGiovanna Palladino Giovanna Palladino
Giovanna Palladino Giovanna Palladino
GIGiuseppe Imperio
Giuseppe Imperio
AVAndrea Ventura
Andrea Ventura
AFAlessandro Federico
Alessandro Federico

7 November 2023 in World Journal of Gastroenterology
Verified
Journal Article
Open access
AGAntonietta Gerarda Gravina
Antonietta Gerarda Gravina
Raffaele PellegrinoRaffaele Pellegrino
Raffaele Pellegrino
TDTommaso Durante
Tommaso Durante
GPGiovanna Palladino
Giovanna Palladino
RDRossella D’oNofrio
Rossella D’oNofrio
AFAlessandro Federico
Alessandro Federico
Inflammatory bowel disease (IBD) has as a main characteristic the exacerbation of the immune system against enterocytes, compromising the individual’s intestinal microbiota. This inflammatory cascade causes several nutritional deficiencies, which further compromise immunological functioning and, as a result, worsen the prognosis. This vicious cycle can be interrupted as the patient’s dietary pattern meets their needs according to their clinical condition, acting directly on the inflammatory process of IBD through the interaction of food, intestinal microbiota, and epigenome. Specific nutritional intervention for IBD has a crucial role in preventing and managing disease activity. This review addresses epigenetic modifications through dietary compounds as a mechanism for modulating the intestinal microbiota of patients with IBD.

7 January 2024 in World Journal of Gastroenterology
Verified
Journal Article
Open access
AGAntonietta Gerarda Gravina
Antonietta Gerarda Gravina
Raffaele PellegrinoRaffaele Pellegrino
Raffaele Pellegrino
MCMarina Cipullo
Marina Cipullo
GPGiovanna Palladino
Giovanna Palladino
GIGiuseppe Imperio
Giuseppe Imperio
AFAlessandro Federico
Alessandro Federico
Artificial intelligence is increasingly entering everyday healthcare. Large language model (LLM) systems such as Chat Generative Pre-trained Transformer (ChatGPT) have become potentially accessible to everyone, including patients with inflammatory bowel diseases (IBD). However, significant ethical issues and pitfalls exist in innovative LLM tools. The hype generated by such systems may lead to unweighted patient trust in these systems. Therefore, it is necessary to understand whether LLMs (trendy ones, such as ChatGPT) can produce plausible medical information (MI) for patients. This review examined ChatGPT’s potential to provide MI regarding questions commonly addressed by patients with IBD to their gastroenterologists. From the review of the outputs provided by ChatGPT, this tool showed some attractive potential while having significant limitations in updating and detailing information and providing inaccurate information in some cases. Further studies and refinement of the ChatGPT, possibly aligning the outputs with the leading medical evidence provided by reliable databases, are needed.

28 May 2023 in World Journal of Gastroenterology
Verified
Journal Article
Open access
AGAntonietta Gerarda Gravina
Antonietta Gerarda Gravina
Raffaele PellegrinoRaffaele Pellegrino
Raffaele Pellegrino
SASalvatore Auletta
Salvatore Auletta
GPGiovanna Palladino
Giovanna Palladino
GBGiovanni Brandimarte
Giovanni Brandimarte
AFAlessandro Federico
Alessandro Federico
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases

26 April 2022 in Andrology
Verified
Journal Article
Open access
LRLorenzo Romano
Lorenzo Romano
Raffaele PellegrinoRaffaele Pellegrino
Raffaele Pellegrino
CSCarmine Sciorio
Carmine Sciorio
Biagio BaroneBiagio Barone
Biagio Barone
AGAntonietta Gerarda Gravina
Antonietta Gerarda Gravina
FCFelice Crocetto
Felice Crocetto
Introduction: Sexual function is often impaired in patients with chronic illnesses. Several patients with chronic gastrointestinal and liver disorders have been shown to suffer from sexual dysfunction, and celiac disease is a highly prevalent gastroenterological disorder.Aim: The aim of this study was to investigate the sexual function incidence and the risk factors for sexual dysfunction in both male and female celiac disease patients.Methods: Two hundred and eighty‐four patients (170 females, 114 males) participated in this cross‐sectional observational study in an anonymous manner. Female sexual function was assessed through the Female Sexual Function Index questionnaire. Male sexual function was assessed through the International Index of Erectile Function‐5 questionnaire. Clinical‐demographic variables were recorded. We investigated differences in the patient‐reported outcomes among the different subgroups and whether there were clinical‐demographic predictors of sexual dysfunction in our setting.Main outcome measures: Prevalence and assessment of sexual dysfunction in celiac disease patients.Results: In the female group, 85 subjects (50%) had a total score compatible with sexual dysfunction: 43 (61.42%) showed low desire, 79 (46.47%) showed arousal disorder, 66 (38.82%) lubrication disorder, and 84 (49.41%) inability of obtaining an orgasm. Also, a large proportion of our female patients, 161 (94.70%), showed sexual discomfort during intercourse. In the male group, 79 patients (62.2%) showed scores compatible with normal erectile function, eight (7.01%) had mild erectile dysfunction, 24 (21.05%) mild to moderate erectile dysfunction, and three (2.63%) presented severe erectile dysfunction. Altered body mass index was significantly associated with sexual dysfunction both in male and female patients. Early age at diagnosis was a significant predictor of sexual dysfunction in male celiac disease patients.Conclusions: A significant proportion of celiac disease patients present sexual dysfunction. Early age at diagnosis and high body mass index seem to predict sexual dysfunction in this clinical setting. Assessment of sexual function should be part of the initial evaluation of celiac disease patients in order to establish a prompt diagnosis and early treatment.